Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17646111 | 0.95 | TSHR (0.35) | TSHRTHRB | |
| SCHEMBL16322551 | 0.94 | TSHR (0.39) | TSHRTHRB | |
| SCHEMBL28456926 | 0.87 | THRB (0.46) | TSHRTHRBPOLBAPEX1HTT | |
| Hydrochloric Acid SCHEMBL28502809 | 0.85 | THRB (0.44) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16323040 | 0.85 | PTGES (0.38) | POLBAPEX1HTTTDP1ALDH1A1 | |
| SCHEMBL16322292 | 0.85 | TSHR (0.35) | TSHRTHRB | |
| SCHEMBL16322492 | 0.83 | TSHR (0.36) | TSHRTHRB | |
| SCHEMBL275291 | 0.81 | THRB (0.41) | TSHRTHRBPOLBAPEX1HTT | |
| SCHEMBL16323159 | 0.80 | MTNR1A (0.38) | POLBAPEX1HTTTDP1 | |
| SCHEMBL21670453 | 0.80 | THRB (0.54) | TSHRTHRBPOLBAPEX1HTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3461811-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M Innovative Properties Co. (US) | 2019-04-03 | — | — | EP | disclosed |
| US-10239828-B2 | Process for preparing guanidino-functional monomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2019-03-26 | — | — | US | disclosed |
| EP-3010883-B1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES CO (US) | 2019-02-20 | — | — | EP | disclosed |
| US-20170183299-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2017-06-29 | — | — | US | disclosed |
| US-9670149-B2 | Process for preparing guanidino-functional monomers | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2017-06-06 | — | — | US | disclosed |
| EP-3010883-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M Innovative Properties Company (US) | 2016-04-27 | — | — | EP | disclosed |
| US-20160096802-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | SOLVENTUM INTELLECTUAL PROPERTIES COMPANY | 2016-04-07 | — | — | US | disclosed |
| WO-2014204763-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-12-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160096802-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | GMPS, GUCY1B2, GUCY1A1 | TSHR 4368/4885THRB 4332/4885POLB 409/4885 |
| US-10239828-B2 | Process for preparing guanidino-functional monomers | GMPS, GUCY1B2, GUCY1A1 | TSHR 4368/4885THRB 4332/4885POLB 409/4885 |
| US-20170183299-A1 | PROCESS FOR PREPARING GUANIDINO-FUNCTIONAL MONOMERS | GMPS, GUCY1B2, GUCY1A1 | TSHR 4368/4885THRB 4332/4885POLB 409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.